Clinical Trials Logo

Filter by:
NCT ID: NCT03675516 Completed - Clinical trials for Rheumatoid Arthritis

Comorbidities and Outcomes in Early Rheumatoid Arthritis

Start date: March 1, 2004
Phase:
Study type: Observational

Identify the burden of comorbidity at the time of diagnosis of rheumatoid arthritis. Identify the impact of comorbidity present at diagnosis on cardiovascular disease, death, rheumatoid arthritis disease progression and infections.

NCT ID: NCT03675165 Completed - Clinical trials for Diabetes Mellitus, Type 2

Can You Reduce Diabetes Symptomatology by Becoming Your 'Best Possible Self': The Role of Stress and Resilience

Start date: August 28, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how the 'Best Possible Self' (BPS) intervention influences diabetes symptomatology over a four week period by assessing stress and resilience as mediatory effects. Half of the participants will receive the BPS straight away while the other half will be put on a waiting list and will act as the control group.

NCT ID: NCT03674086 Completed - Clinical trials for Hearing Loss, Sensorineural

Evaluation of the eAdjust Application

Start date: August 23, 2018
Phase:
Study type: Observational

Despite being effective, the majority of people who would benefit from using hearing aids do not access them. For those who do obtain hearing aids, around 20% do not wear them regularly. People often do not use their hearing aids because they continue to experience difficulties when listening to and understanding speech in noisy situations. Conventional hearing aids must be programmed and adjusted by a trained audiologist with specialist equipment and therefore provide limited user-control over the hearing aid's functionality. In comparison to conventional hearing aids, Smartphone-connected hearing aids enable patients to adjust their programmes themselves in different situations using a Smartphone application. Smartphone-connectivity can supplement clinical practices, as patients can adjust their hearing aids without the need to visit the clinic. This has the potential to empower patients to be actively involved in their own hearing healthcare. A systematic review assessing the effectiveness of alternative listening devices showed that there is no published high-quality research assessing the clinical effectiveness of Smartphone-connected hearing aids. Furthermore, a usability research study has shown that patients want to personalise and adjust their own HA programmes to meet their individual needs. Having carried out the early development work, the next step would be to carry out a study to evaluate smartphone-connected hearing aids, in accordance with the MRC guidelines on developing and evaluating complex interventions. This study will assess the benefits of a smartphone application, eAdjust that has been developed for use with Phonak Audeo B90-Direct hearing aids. The eAdjust app connects to the hearing aid via Bluetooth, and enables hearing aid users to fine-tune their hearing aids via their smartphone. The benefits of the eAdjust app will be assessed in the real-world as well as in the laboratory. A mixed methods approach will be taken, using both behavioural and patient reported outcomes.

NCT ID: NCT03673982 Completed - Anorexia Nervosa Clinical Trials

Carer Skills Training for Inpatients With Anorexia Nervosa (iCASK)

iCASK
Start date: January 9, 2017
Phase: N/A
Study type: Interventional

To improve treatment for patients with severe anorexia nervosa admitted for inpatient care, and to help their families. Inpatients and their families will be offered a novel intervention which includes multimedia training materials. These materials provide guidance in how families can provide support to maintain and build on changes made during inpatient care

NCT ID: NCT03673930 Completed - Cognitive Change Clinical Trials

Cognitive and Cerebral Blood Flow Effects of Zanthozylum Armatum Fruit Extract in Healthy Adults Aged 30 - 55

Start date: April 6, 2018
Phase: N/A
Study type: Interventional

Zanthozylum armatum (Z. armatum)—otherwise known as Nepalese pepper, or timut—is an perennial shrub found in India and across Southeast Asia. Preparations of the bark, fruit and seeds of Z. armatum have been extensively used in traditional Indian medicine. Preliminary data have indicated that preparations of Z. armatum may also be beneficial to cognitive function. The study aims to investigate the effects acute and chronic consumption of Z. armatum on cognitive function and cerebral blood flow.

NCT ID: NCT03673722 Completed - Dementia Clinical Trials

Mediterranean Diet, Exercise and Dementia Risk in UK Adults

MedEx-UK
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

In cohort studies, a Mediterranean Dietary Pattern (MDP) has been consistently associated with reduced dementia incidence. The efficacy of a MDP to prevent dementia has never been directly demonstrated by RCTs, with existing research limited to cognition as a secondary outcome. Furthermore, despite their likely additive effects, the combined impact of Physical Activity (PA) and a MDP on dementia risk is unknown. MedEx-UK is a RCT that will evaluate the feasibility of a multi-domain intervention to increase Mediterranean Dietary Pattern (MDP) adherence and physical activity (PA) in a group of older UK adults who are at above average risk of dementia.

NCT ID: NCT03673683 Completed - Ventilator Weaning Clinical Trials

Sedation and Weaning in Children Requiring Invasive Mechanical Ventilation

SANDWICH
Start date: February 5, 2018
Phase: N/A
Study type: Interventional

A UK multi-centre cluster randomised controlled trial to determine if a protocol-based intervention incorporating coordinated care with greater nursing involvement to managing sedation and ventilator weaning can reduce the duration of invasive mechanical ventilation and is cost effective compared with usual care in children in Pediatric Intensive Care Units.

NCT ID: NCT03673670 Completed - COPD Clinical Trials

Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD

Start date: July 16, 2018
Phase: Phase 2
Study type: Interventional

The study investigates the effect of 3 days of twice daily treatment of two different doses of RPL554 (a phosphodiesterase [PDE]3/4 inhibitor) or placebo, each administered in addition to once daily tiotropium/olodaterol (Respimat) in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Patients will receive each of the three treatment combinations in a randomized sequence using a crossover design

NCT ID: NCT03673111 Completed - Obesity Clinical Trials

Study of the Gut Hormone Analogue Y14 in Adult Subjects

Start date: May 10, 2017
Phase: Phase 1
Study type: Interventional

A randomised, placebo controlled Phase I study to investigate investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of Y14 in adult subjects.

NCT ID: NCT03672994 Completed - Healthy Clinical Trials

Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient

EMBER
Start date: February 2, 2017
Phase:
Study type: Observational

An acute study carried out across three acute admissions units within Leicestershire. The study is aimed at discovery and validation of volatile organic compounds (VOCs) in exhaled breath. Participants will be recruited and tested within 24 hours of admission and once recovered, up to 6 months following discharge.